Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001639837-15-000002
Filing Date
2015-04-17
Accepted
2015-04-17 15:05:23
Documents
1
Effectiveness Date
2015-04-17
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8124
  Complete submission text file 0001639837-15-000002.txt   9171
Mailing Address 10900 WILSHIRE BLVD., SUITE 850 LOS ANGELES CA 90024
Business Address 10900 WILSHIRE BLVD., SUITE 850 LOS ANGELES CA 90024 310-405-7212
Triangle Therapeutics Inc. (Filer) CIK: 0001639837 (see all company filings)

EIN.: 462817645 | State of Incorp.: CA | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-238224 | Film No.: 15777753